Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Current Assets (2019 - 2025)

Outset Medical (OM) has disclosed Current Assets for 7 consecutive years, with $250.9 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 2.84% to $250.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $250.9 million through Dec 2025, down 2.84% year-over-year, with the annual reading at $250.9 million for FY2025, 2.84% down from the prior year.
  • Current Assets for Q4 2025 was $250.9 million at Outset Medical, down from $265.4 million in the prior quarter.
  • The five-year high for Current Assets was $448.0 million in Q2 2021, with the low at $250.9 million in Q4 2025.
  • Average Current Assets over 5 years is $323.7 million, with a median of $309.7 million recorded in 2022.
  • The sharpest move saw Current Assets rose 18.47% in 2021, then fell 28.46% in 2022.
  • Over 5 years, Current Assets stood at $409.8 million in 2021, then decreased by 8.82% to $373.6 million in 2022, then dropped by 22.06% to $291.2 million in 2023, then dropped by 11.33% to $258.2 million in 2024, then decreased by 2.84% to $250.9 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $250.9 million, $265.4 million, and $275.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.